title: Drug Pricing Trends for Orally Administered Anticancer Medications Reimbursed by Commercial Health Plans, 2000-2014.
authors.affiliation: Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill2Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill.
authors.forename: Stacie B
authors.initials: SB
authors.lastname: Dusetzina
mesh_terms: D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D016527:Drug Costs / Q000331:legislation & jurisprudence; D006291:Health Policy; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000191:economics* / Q000331:legislation & jurisprudence; D009369:Neoplasms / Q000188:drug therapy* / Q000191:economics
chemical_list: D000970:Antineoplastic Agents